Michael Nagel - 05 Oct 2023 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role
Director
Signature
/s/ Michael Nagel
Issuer symbol
KRBPQ
Transactions as of
05 Oct 2023
Net transactions value
$0
Form type
4
Filing time
06 Oct 2023, 16:07:01 UTC
Previous filing
05 Jul 2022
Next filing
20 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRBP Restricted Stock Units Award $0 +18,000 $0.000000 18,000 05 Oct 2023 Common Stock 18,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU.